Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Patient Study of JAK/STAT Inhibition in CNS Kohlmeier-Degos Disease

NCT05998395 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT05998395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05998395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Patient Study of JAK/STAT Inhibition in CNS Kohlmeier-Degos Disease
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Phase 1/2
Overall status
Completed
Start date
September 28, 2023
Completion date
February 28, 2025
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kohlmeier degos disease with neurologic involvement, kohlmeier-degos disease